Lahiri Ashok 4

4 · Enovix Corp · Filed Jul 16, 2021

Form 4

Period: 2021-07-14

Chief Technology Officer

Transactions

Award
Stock Option (Right to Buy)
2021-07-14+141,376→ 141,376 total
Exercise: $9.26Exp: 2031-04-19→ Common Stock (141,376 underlying)
Award
Stock Option (Right to Buy)
2021-07-14+21,538→ 21,538 total
Exercise: $0.05Exp: 2027-12-13→ Common Stock (21,538 underlying)
Award
Common Stock
2021-07-14+1,351,031→ 1,351,031 total

Footnotes (5)

[F1]Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.
[F2]The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, September 1, 2017, subject to Reporting Person's continuous service through each such vesting date.
[F3]Received in exchange for a stock option to purchase 116,667 shares of Legacy Enovix Common Stock.
[F4]The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.
[F5]Received in exchange for a stock option to purchase 765,800 shares of Legacy Enovix Common Stock.

Documents

2 files